Is your QC Lab documenting the re-injection of samples?

A company recently received this 483 observation: 

…..Laboratory controls do not include the establishment of scientifically sound and appropriate specifications, standards and test procedures designed to assure that components, in-process materials and drug products conform to appropriate standards of identity, strength, quality and purity.

Specifically, there is no documentation or justification if GC and/or HPLC runs are repeated or aborted. For example, your firm performed a re-injection of ….. drug product sample, Lot ….., without documentation or explanation.

For more details on this observation as well as other observations pertaining to Laboratory Controls see  Issue 1019 available today.  It features observations pertaining to Active Pharmaceutical Ingredient (API) Manufacturing on our rotating page 3 topic as well as Medical Device Manufacturing Controls and Manufacturing Controls.

Leave a Reply

Your email address will not be published. Required fields are marked *

Search GMP Trends

Did you know: Our entire report archive has been indexed! This means, our members can search across thousands of 483 observations and pinpoint the exact info they need!